Trastuzumab cost effective in HER2-positive metastatic gastric cancer
Source: PharmacoEconomics and Outcomes News - Category: Drugs & Pharmacology Source Type: news
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Gastric (Stomach) Cancer | Gastroenterology | HER2 | Herceptin